1061 related articles for article (PubMed ID: 14506670)
41. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.
Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F
Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341
[TBL] [Abstract][Full Text] [Related]
42. DNA flow cytometry but not telomerase activity as predictor of disease-free survival in pT1-2/N0/G2 breast cancer.
Pinto AE; André S; Pereira T; Silva G; Soares J
Pathobiology; 2006; 73(2):63-70. PubMed ID: 16943686
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic value of DNA flow cytometry combined with fine needle aspiration biopsy in lymphomas.
Joensuu H; Klemi PJ; Eerola E
J Pathol; 1988 Mar; 154(3):237-45. PubMed ID: 3351670
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of DNA image cytometry in Libyan breast cancer.
Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
[TBL] [Abstract][Full Text] [Related]
45. Predictive value of cell kinetics in endometrial adenocarcinoma.
Mariani L; Conti L; Antenucci A; Vercillo M; Atlante M; Gandolfo GM
Anticancer Res; 2000; 20(5B):3569-74. PubMed ID: 11131664
[TBL] [Abstract][Full Text] [Related]
46. Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates.
Baldetorp B; Bendahl PO; Fernö M; Alanen K; Delle U; Falkmer U; Hansson-Aggesjö B; Höckenström T; Lindgren A; Mossberg L
Cytometry; 1995 Jun; 22(2):115-27. PubMed ID: 7587742
[TBL] [Abstract][Full Text] [Related]
47. S-phase fraction as an independent prognostic factor of long-term overall survival in patients with early-stage or locally advanced invasive breast carcinoma.
Vielh P; Carton M; Padoy E; de Rycke Y; Klijanienko J; El-Naggar AK; Asselain B
Cancer; 2005 Dec; 105(6):476-82. PubMed ID: 16116603
[TBL] [Abstract][Full Text] [Related]
48. [Retrospective flow-cytometric analysis of the DNA content in colorectal carcinomas and the test of the prognostic significance of DNA ploidy].
Baretton G; Gille J; Oevermann E; Löhrs U
Verh Dtsch Ges Pathol; 1990; 74():233-7. PubMed ID: 1708591
[TBL] [Abstract][Full Text] [Related]
49. S-phase fraction of 155 soft tissue sarcomas: correlation with clinical outcome.
Huuhtanen RL; Blomqvist CP; Wiklund TA; Virolainen MJ; Elomaa AI; Pan Y; Tribukait B
Cancer; 1996 May; 77(9):1815-22. PubMed ID: 8646679
[TBL] [Abstract][Full Text] [Related]
50. Different calculation methods for flow cytometric S-phase fraction: prognostic implications in breast cancer? The Swedish Society of Cancer Study Group.
Baldetorp B; Stål O; Ahrens O; Cornelisse C; Corver W; Falkmer U; Fernö M
Cytometry; 1998 Dec; 33(4):385-93. PubMed ID: 9845432
[TBL] [Abstract][Full Text] [Related]
51. Prognostic value of S-phase fraction in head and neck squamous cell carcinomas and nodal negative breast carcinomas.
Fietkau R; Iro H; Tulusan AH; Dressel V; Altendorf-Hofmann A; Sauer R
Strahlenther Onkol; 1994 Jan; 170(1):13-24. PubMed ID: 8303573
[TBL] [Abstract][Full Text] [Related]
52. Comparative expression of a set of genes to an internal housekeeping control in CDNA amplified and not amplified by PolyAPCR in non-Hodgkin's lymphoma samples obtained from fine-needle aspiration cytology.
Corbi FC; Inaoka RJ; Felix RS; Andrade VC; Etto LY; Vettore AL; Franco MF; Colleoni GW
Diagn Mol Pathol; 2010 Mar; 19(1):40-4. PubMed ID: 20186011
[TBL] [Abstract][Full Text] [Related]
53. Granulosa cell tumor of ovary: a clinicopathologic and flow cytometric DNA analysis.
Roush GR; el-Naggar AK; Abdul-Karim FW
Gynecol Oncol; 1995 Mar; 56(3):430-4. PubMed ID: 7705680
[TBL] [Abstract][Full Text] [Related]
54. Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma.
Pinto AE; Silva G; Banito A; Leite V; Soares J
Oncol Rep; 2008 Oct; 20(4):913-9. PubMed ID: 18813835
[TBL] [Abstract][Full Text] [Related]
55. Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry.
Baldetorp B; Fernö M; Fallenius A; Fallenius-Vecchi G; Idvall I; Olsson H; Sigurdsson H; Akerman M; Killander D
Cytometry; 1992; 13(6):577-85. PubMed ID: 1451590
[TBL] [Abstract][Full Text] [Related]
56. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
Meyer JS; Gersell DJ; Yim S
Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
[TBL] [Abstract][Full Text] [Related]
57. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
[TBL] [Abstract][Full Text] [Related]
58. Immunophenotype, histopathology and clinical stage: their predictive value in the prognosis of non-Hodgkin's lymphomas.
Mtasiwa DM; Imamura N; Inada T; Takimoto Y; Okada K; Nanba K; Asaoku H; Kuramoto A
Hiroshima J Med Sci; 1990 Dec; 39(4):95-102. PubMed ID: 2086567
[TBL] [Abstract][Full Text] [Related]
59. Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma.
Mazzei T; Tonelli F; Mini E; Mazzoni P; Pesciullesi A; Valanzano R; Ficari F; Biondi C; Periti P
Anticancer Res; 1995; 15(5B):2247-53. PubMed ID: 8572632
[TBL] [Abstract][Full Text] [Related]
60. Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis.
Bratt O; Anderson H; Bak-Jensen E; Baldetorp B; Lundgren R
Urology; 1996 Feb; 47(2):218-24. PubMed ID: 8607238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
